Literature DB >> 8690809

Evidence for a catabolic role of glucagon during an amino acid load.

M R Charlton1, D B Adey, K S Nair.   

Abstract

Despite the strong association between protein catabolic conditions and hyperglucagonemia, and enhanced glucagon secretion by amino acids (AA), glucagon's effects on protein metabolism remain less clear than on glucose metabolism. To clearly define glucagon's catabolic effect on protein metabolism during AA load, we studied the effects of glucagon on circulating AA and protein dynamics in six healthy subjects. Five protocols were performed in each subject using somatostatin to inhibit the secretion of insulin, glucagon, and growth hormone (GH) and selectively replacing these hormones in different protocols. Total AA concentration was the highest when glucagon, insulin, and GH were low. Selective increase of glucagon levels prevented this increment in AA. Addition of high levels of insulin and GH to high glucagon had no effect on total AA levels, although branched chain AA levels declined. Glucagon mostly decreased glucogenic AA and enhanced glucose production. Endogenous leucine flux, reflecting proteolysis, decreased while leucine oxidation increased in protocols where AA were infused and these changes were unaffected by the hormones. Nonoxidative leucine flux reflecting protein synthesis was stimulated by AA, but high glucagon attenuated this effect. Addition of GH and insulin partially reversed the inhibitory effect of glucagon on protein synthesis. We conclude that glucagon is the pivotal hormone in amino acid disposal during an AA load and, by reducing the availability of AA, glucagon inhibits protein synthesis stimulated by AA. These data provide further support for a catabolic role of glucagon at physiological concentrations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690809      PMCID: PMC507404          DOI: 10.1172/JCI118782

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Effects of glucagon on general protein degradation and synthesis in perfused rat liver.

Authors:  K H Woodside; W F Ward; G E Mortimore
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

2.  High performance liquid chromatographic determination of amino acids in the picomole range.

Authors:  D W Hill; F H Walters; T D Wilson; J D Stuart
Journal:  Anal Chem       Date:  1979-07       Impact factor: 6.986

3.  Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis.

Authors:  P Castellino; L Luzi; D C Simonson; M Haymond; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Effect of glucagon on plasma alanine and glutamine metabolism and hepatic gluconeogenesis in sheep.

Authors:  R P Brockman; E N Bergman
Journal:  Am J Physiol       Date:  1975-06

5.  Hyperglucagonaemia in the surgical patient.

Authors:  R C Russell; C J Walker; S R Bloom
Journal:  Br Med J       Date:  1975-01-04

6.  Insulin and glucagon stimulation of amino acid transport in isolated rat hepatocytes. Synthesis of a high affinity component of transport.

Authors:  M Fehlmann; A Le Cam; P Freychet
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

7.  Hormonal regulation of amino acid transport and cAMP production in monolayer cultures of rat hepatocytes.

Authors:  D S Kelley; J D Shull; V R Potter
Journal:  J Cell Physiol       Date:  1980-04       Impact factor: 6.384

8.  Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.

Authors:  G Boden; R W Master; I Rezvani; J P Palmer; T E Lobe; O E Owen
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

9.  In-vivo measurement of glucose and alanine metabolism with stable isotopic tracers.

Authors:  D M Bier; K J Arnold; W R Sherman; W H Holland; W F Holmes; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

10.  Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C]leucine.

Authors:  D E Matthews; K J Motil; D K Rohrbaugh; J F Burke; V R Young; D M Bier
Journal:  Am J Physiol       Date:  1980-05
View more
  23 in total

1.  The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: A metabolic role of the kidney.

Authors:  N Møller; S Meek; M Bigelow; J Andrews; K S Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 3.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

4.  Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes.

Authors:  Adam R Konopka; Raul Ruiz Esponda; Matthew M Robinson; Matthew L Johnson; Rickey E Carter; Michele Schiavon; Claudio Cobelli; Fredric E Wondisford; Ian R Lanza; K Sreekumaran Nair
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

5.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

6.  Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume.

Authors:  Masami Hiroyama; Toshinori Aoyagi; Yoko Fujiwara; Sayuri Oshikawa; Atsushi Sanbe; Fumio Endo; Akito Tanoue
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

7.  Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.

Authors:  Jinrang Kim; Haruka Okamoto; ZhiJiang Huang; Guillermo Anguiano; Shiuhwei Chen; Qing Liu; Katie Cavino; Yurong Xin; Erqian Na; Rachid Hamid; Joseph Lee; Brian Zambrowicz; Roger Unger; Andrew J Murphy; Yan Xu; George D Yancopoulos; Wen-Hong Li; Jesper Gromada
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

8.  The effect of branched chain amino acids on skeletal muscle mitochondrial function in young and elderly adults.

Authors:  Laura L Tatpati; Brian A Irving; Andrea Tom; Maureen L Bigelow; Katherine Klaus; Kevin R Short; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2009-12-18       Impact factor: 5.958

9.  Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism.

Authors:  Kevin R Short; Brian A Irving; Ananda Basu; C Michael Johnson; K Sreekumaran Nair; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

Review 10.  Protein and energy metabolism in type 1 diabetes.

Authors:  Sadie L Hebert; K Sreekumaran Nair
Journal:  Clin Nutr       Date:  2009-09-27       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.